Technical Analysis for HEPA - Hepion Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.07 | 4.89% | 0.05 |
HEPA closed up 4.89 percent on Monday, July 1, 2024, on 35 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 4.89% | |
NR7 | Range Contraction | 4.89% |
Alert | Time |
---|---|
Gap Up Closed | about 7 hours ago |
Outside Day | about 7 hours ago |
Down 5% | about 7 hours ago |
Down 3% | about 7 hours ago |
Fell Below Lower Bollinger Band | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Phosphates Hepatitis B Lipid Liver Disease Hepatotoxins Treatment Of Hepatitis Cyclophilin Drug Therapy Gilead Sciences Chronic Liver Diseases Treatment Of Hepatitis B Chronic Liver Disease Tenofovir Disoproxil
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Phosphates Hepatitis B Lipid Liver Disease Hepatotoxins Treatment Of Hepatitis Cyclophilin Drug Therapy Gilead Sciences Chronic Liver Diseases Treatment Of Hepatitis B Chronic Liver Disease Tenofovir Disoproxil
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.07 |
52 Week Low | 0.9 |
Average Volume | 38,302 |
200-Day Moving Average | 2.67 |
50-Day Moving Average | 1.23 |
20-Day Moving Average | 1.10 |
10-Day Moving Average | 1.05 |
Average True Range | 0.12 |
RSI (14) | 43.82 |
ADX | 28.36 |
+DI | 9.59 |
-DI | 24.42 |
Chandelier Exit (Long, 3 ATRs) | 1.00 |
Chandelier Exit (Short, 3 ATRs) | 1.26 |
Upper Bollinger Bands | 1.22 |
Lower Bollinger Band | 0.98 |
Percent B (%b) | 0.37 |
BandWidth | 21.94 |
MACD Line | -0.06 |
MACD Signal Line | -0.08 |
MACD Histogram | 0.0123 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.29 | ||||
Resistance 3 (R3) | 1.28 | 1.18 | 1.26 | ||
Resistance 2 (R2) | 1.18 | 1.13 | 1.19 | 1.24 | |
Resistance 1 (R1) | 1.13 | 1.09 | 1.08 | 1.14 | 1.23 |
Pivot Point | 1.03 | 1.03 | 1.01 | 1.04 | 1.03 |
Support 1 (S1) | 0.98 | 0.98 | 0.93 | 1.00 | 0.91 |
Support 2 (S2) | 0.88 | 0.94 | 0.89 | 0.90 | |
Support 3 (S3) | 0.83 | 0.88 | 0.88 | ||
Support 4 (S4) | 0.85 |